Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastoma

European Journal of Cancer

Volumn 43, Issue 3, 2007, Pages 607-616

  Henrich, Kai Oliver ^a   Claas, Andreas ^a   Praml, Christian ^a   Benner, Axel ^a   Mollenhauer, Jan ^a   Poustka, Annemarie ^a   Schwab, Manfred ^a   Westermann, Frank ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

1p; CAMTA1; Deletion; FLJ10737; LOH; Neuroblastoma

Indexed keywords

COMPLEMENTARY DNA;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD SAMPLING; CAMTA1 GENE; CHROMOSOME 1P; CONTROLLED STUDY; FLJ10737 GENE; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; HEMIZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN DOMAIN; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC MUTATION;

ALLELES; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; HUMANS; NEUROBLASTOMA; PROTEINS; SEQUENCE ANALYSIS; TRANS-ACTIVATORS;

EID: 33846645319     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.09.023     Document Type: Article

References (42)

1. Brodeur G.M., Seeger R.C., Schwab M., Varmus H.E., and Bishop J.M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224 4653 (1984) 1121-1124
2. Schwab M., Alitalo K., Klempnauer K.H., et al. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305 5931 (1983) 245-248
3. Maris J.M., Weiss M.J., Guo C., et al. Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study. J Clin Oncol 18 9 (2000) 1888-1899
4. Attiyeh E.F., London W.B., Mosse Y.P., et al. Chromosome 1p and 11q deletions and outcome in neuroblastoma. New Engl J Med 353 21 (2005) 2243-2253
5. Bader S.A., Fasching C., Brodeur G.M., and Stanbridge E.J. Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells. Cell Growth Differ 2 5 (1991) 245-255
6. Fong C.T., Dracopoli N.C., White P.S., et al. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc Natl Acad Sci USA 86 10 (1989) 3753-3757
7. Weith A., Martinsson T., Cziepluch C., et al. Neuroblastoma consensus deletion maps to 1p36.1-2. Genes Chromosomes Cancer 1 2 (1989) 159-166
8. Schleiermacher G., Peter M., Michon J., et al. Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chromosomes Cancer 10 4 (1994) 275-281
9. Takeda O., Homma C., Maseki N., et al. There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chromosomes Cancer 10 1 (1994) 30-39
10. Martinsson T., Sjoberg R.M., Hedborg F., and Kogner P. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms. Cancer Res 55 23 (1995) 5681-5686
11. White P.S., Maris J.M., Beltinger C., et al. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci USA 92 12 (1995) 5520-5524
12. Schwab M., Praml C., and Amler L.C. Genomic instability in 1p and human malignancies. Genes Chromosomes Cancer 16 4 (1996) 211-229
13. Caron H., Spieker N., Godfried M., et al. Chromosome bands 1p35-36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted. Genes Chromosomes Cancer 30 2 (2001) 168-174
14. Ohira M., Kageyama H., Mihara M., et al. Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line. Oncogene 19 37 (2000) 4302-4307
15. Henrich K.O., Fischer M., Mertens D., et al. Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients. Clin Cancer Res 12 1 (2006) 131-138
16. Bauer A., Savelyeva L., Claas A., Praml C., Berthold F., and Schwab M. Smallest region of overlapping deletion in 1p36 in human neuroblastoma: a 1 Mbp cosmid and PAC contig. Genes Chromosomes Cancer 31 3 (2001) 228-239
17. Hogarty M.D., Liu X., Guo C., et al. Identification of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomas. Med Pediatr Oncol 35 6 (2000) 512-515
18. White P.S., Thompson P.M., Gotoh T., et al. Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma. Oncogene 24 16 (2005) 2684-2694
19. White P.S., Thompson P.M., Seifried B.A., et al. Detailed molecular analysis of 1p36 in neuroblastoma. Med Pediatr Oncol 36 1 (2001) 37-41
20. Katoh M., and Katoh M. Identification and characterization of FLJ10737 and CAMTA1 genes on the commonly deleted region of neuroblastoma at human chromosome 1p36.31-p36.23. Int J Oncol 23 4 (2003) 1219-1224
21. Kelley W.L. The J-domain family and the recruitment of chaperone power. Trends Biochem Sci 23 6 (1998) 222-227
22. Kurzik-Dumke U., Gundacker D., Renthrop M., and Gateff E. Tumor suppression in Drosophila is causally related to the function of the lethal(2) tumorous imaginal discs gene, a dnaJ homolog. Dev Genet 16 1 (1995) 64-76
23. Syken J., De-Medina T., and Munger K. TID1, a human homolog of the Drosophila tumor suppressor l(2)tid, encodes two mitochondrial modulators of apoptosis with opposing functions. Proc Natl Acad Sci USA 96 15 (1999) 8499-8504
24. Bouché N., Scharlat A., Snedden W., Bouchez D., and Fromm H. A novel family of calmodulin-binding transcription activators in multicellular organisms. J Biol Chem 277 24 (2002) 21851-21861
25. Nakatani K., Nishioka J., Itakura T., et al. Cell cycle-dependent transcriptional regulation of calmodulin-binding transcription activator 1 in neuroblastoma cells. Int J Oncol 24 6 (2004) 1407-1412
26. Nagase T., Ishikawa K., Suyama M., et al. Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res 5 6 (1998) 355-364
27. Barbashina V., Salazar P., Holland E.C., Rosenblum M.K., and Ladanyi M. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and valuation of CAMTA1 as a candidate tumor suppressor gene. Clin Cancer Res 11 3 (2005) 1119-1128
28. Walz T., Geisel J., Bodis M., Knapp J.P., and Herrmann W. Fluorescence-based single-strand conformation polymorphism analysis of mutations by capillary electrophoresis. Electrophoresis 21 2 (2000) 375-379
29. Antonarakis S.E. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat 11 1 (1998) 1-3
30. Emigh T. Comparison of tests for Hardy-Weinberg Equilibrium. Biometrics 36 (1980) 627-642
31. R Development Core Team. R: A language and environment for statistical computing. In: R Foundation for Statistical Computing. Vienna; 2003.
32. Chu C.S., Trapnell B.C., Curristin S., Cutting G.R., and Crystal R.G. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet 3 2 (1993) 151-156
33. Sedgwick S.G., and Smerdon S.J. The ankyrin repeat: a diversity of interactions on a common structural framework. Trends Biochem Sci 24 8 (1999) 311-316
34. Kozak M. Emerging links between initiation of translation and human diseases. Mamm Genome 13 8 (2002) 401-410
35. Hellen C.U., and Sarnow P. Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev 15 13 (2001) 1593-1612
36. Yueh A., and Schneider R.J. Translation by ribosome shunting on adenovirus and hsp70 mRNAs facilitated by complementarity to 18S rRNA. Genes Dev 14 4 (2000) 414-421
37. Mosavi L.K., Cammett T.J., Desrosiers D.C., and Peng Z.Y. The ankyrin repeat as molecular architecture for protein recognition. Protein Sci 13 6 (2004) 1435-1448
38. Mollenhauer J., Herbertz S., Holmskov U., et al. DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. Cancer Res 60 6 (2000) 1704-1710
39. Hu Y.J., and Diamond A.M. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res 63 12 (2003) 3347-3351
40. Tavtigian S.V., Simard J., Teng D.H., et al. A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet 27 2 (2001) 172-180
41. Ewart-Toland A., Briassouli P., de Koning J.P., et al. Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nat Genet 34 4 (2003) 403-412
42. Balmain A., Gray J., and Ponder B. The genetics and genomics of cancer. Nat Genet 33 Suppl. (2003) 238-244